XENE Xenon Pharmaceuticals Inc. Yalpi foyda bo'yicha rentabellik

Xenon Corp (XENE) kompaniyasining rasmiy ramzlari

Xenon Pharmaceuticals (XENE) global epilepsiya davolash bozorini egallash uchun o'zining azetukalner dorisi yakuniy sinovlarini kengaytirmoqda. Kompaniya bemorlarning hayot sifatini yaxshilash uchun miya ion kanallariga ta'sir qiluvchi maqsadli terapiyalarni ishlab chiqadi. Valo martja xarajatlarsiz foyda dinamikasini aks ettiradi va uning joriy qiymati 0.00 ni tashkil etadi. Noyob molekulalar uchun olingan patentlar biznesga uzoq muddatli texnologik ustunlikni ta'minlaydi.

Xenon (XENE) Yalpi marja: 04.07.2022 - 20.11.2026 davri uchun

Xenon Corp (XENE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Xenon - XENE
Xenon Pharmaceuticals Inc brend mahsuloti

Investorlar daromadlilikning keskin tebranishlari davrida xavfsizlik illyuziyasiga duch kelmaslik uchun joriy rentabellikni operatsion samaradorlik xatarlari bilan solishtirib baholashlari kerak. 0.00 dagi yalpi foyda koeffitsiyentini tahlil qilib, biz tushumning bevosita xarajatlar chegirilgan qismini baholaymiz, bu esa Xenon Pharmaceuticals (XENE) uchun innovatsion ingibitorlarning yuqori qiymatini va noyob molekulalar uchun patent himoyasining samaradorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi rentabellik Viking Therapeutics VKTX|Yalpi foyda normasi SUPN|CPRX - Yalpi rentabellik|Yalpi foyda marjasi Denali Therapeutics|HRMY: Yalpi marja|Biohaven - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik AMLX|Trevi Therapeutics, Inc. (TRVI) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)